by cbccadmin | Jan 7, 2024 | Uncategorized
We are pleased to announce the induction of David Bearss Ph.D. to our strategic advisory board as a key advisor for clinical trials. Dr. David Bearss is the CEO of Halia Therapeutics, Inc. He is an experienced entrepreneur and drug developer with 20 plus years of...
by cbccadmin | Jan 1, 2024 | Uncategorized
Manoj Vyas (CEO – CBCC Global Research) will be attending The 42nd Annual J. P. Morgan Healthcare Conference, the largest and most informative healthcare investment symposium in the industry, during 8 – 11 January 2024, at San Francisco, CA. For more information on...
by cbccadmin | Feb 1, 2023 | Uncategorized
We are excited to attend DCAT Week, a premier event held annually in New York City for companies engaged in the Global Bio/Pharmaceutical Manufacturing Value Chain. Date: 20 – 23 March, 2023 Location: New York City For more information about this conference,...
by cbccadmin | Jan 19, 2023 | Uncategorized
CBCC Global Research is proud to announce the successful completion of USFDA inspection for Psychiatry PKBE trial with “ZERO 483” at Junagadh site. We congratulate our dedicated team working on this important trial!...
by cbccadmin | Jan 4, 2023 | Uncategorized
Manoj Vyas (CEO – CBCC Global Research) will be attending The 41st Annual J.P.Morgan Healthcare Conference, the largest and most informative healthcare investment symposium in the industry, during 9 – 12 January 2023, at San Francisco, CA. For more information about...
by cbccadmin | Dec 1, 2022 | Uncategorized
Join CBCC Global Research team members Udayan Vyas (AGM – Business Development) and Ajit Upadhyaya (AGM – Business Development) for 17th Biosimilars Congregation 2022 on 13th December, 2022 at Hotel Kohinoor Continental, Mumbai, India. About CBCC Global Research...